Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

by Møller Pål
Published 2004-12-01

Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

by Møller, Pål
Published 2004

The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care

by Møller, Pål
Published in Hered Cancer Clin Pract (2020)

The BRCA2 variant c.68-7 T>A is associated with breast cancer

by Møller, Pål, Hovig, Eivind
Published in Hered Cancer Clin Pract (2017)

Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer

by Møller, Pål, Hovig, Eivind
Published in Hered Cancer Clin Pract (2018)

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

by Møller, Pål, Hovig, Eivind
Published in Med Health Care Philos (2017)

Costs and Benefits of Diagnosing Familial Breast Cancer

by Heimdal, Ketil, Mæhle, Lovise, Møller, Pål
Published 1999

MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis

by Tharmaratnam, Kukatharmini, Hagen, Anne Irene, Møller, Pål
Published in Breast Cancer Res Treat (2014)

No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers

by Møller, Pål, Mæhle, Lovise, Clark, Neal, Apold, Jaran
Published 2007

Uptake of Genetic Testing and Pre-Test Levels of Mental Distress in Norwegian Families with Known BRCA1 Mutations

by Reichelt, Jon G., Dahl, Alv A., Heimdal, Ketil, Møller, Pål
Published 1999

Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift

by Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Published in Cancers (Basel) (2019)

Correction: Møller, P.; et al. Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. Cancers 2019, 11...

by Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Published in Cancers (Basel) (2020)

Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)

by Seppälä, Toni T., Dominguez-Valentin, Mev, Sampson, Julian R., Møller, Pål
Published in Fam Cancer (2020)

MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer

by Stormorken, Astrid, Heintz, Karen-Marie, Andresen, Per Arne, Hovig, Eivind, Møller, Pål
Published 2006

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations

by Borg, Åke, Dørum, Anne, Heimdal, Ketil, Mæhle, Lovise, Hovig, Eivind, Møller, Pål
Published 1999

Survival in Norwegian BRCA1 mutation carriers with breast cancer

by Hagen, Anne Irene, Tretli, Steinar, Mæhle, Lovise, Apold, Jaran, Vedå, Nina, Møller, Pål
Published 2009

Ten modifiers of BRCA1 penetrance validated in a Norwegian series

by Heramb, Cecilie, Ekstrøm, Per Olaf, Tharmaratnam, Kukatharmini, Hovig, Eivind, Møller, Pål, Mæhle, Lovise
Published in Hered Cancer Clin Pract (2015)

Germline PTEN mutations are rare and highly penetrant

by Rustad Cecilie F, Bjørnslett Merete, Heimdal Ketil R, Mæhle Lovise, Apold Jaran, Møller Pål
Published 2006-12-01

Germline PTEN mutations are rare and highly penetrant

by Rustad, Cecilie F, Bjørnslett, Merete, Heimdal, Ketil R, Mæhle, Lovise, Apold, Jaran, Møller, Pål
Published 2006

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

by Møller, Pål, Stormorken, Astrid, Holmen, Marit Muri, Hagen, Anne Irene, Vabø, Anita, Mæhle, Lovise
Published 2014